Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Volume 1 Issue 9, September 2019

Roles of muscle phospholipids in systemic metabolism

Here, the authors show that phospholipids influence whole-body metabolic rate and counteract obesity by altering calcium signalling and inducing energy expenditure in muscle.

See Verkerke et al.

Image: Katsuhiko Funai, University of Utah. Cover Design: Bethany Vukomanovic.

News & Views

  • Systemic accumulation of branched-chain amino acids (BCAAs) is a major metabolic hallmark and contributor to insulin resistance associated with obesity. A recent report identifies SLC25A44 as the BCAA transporter in mitochondrial membranes and shows that BCAA catabolism in brown adipose tissue significantly affects thermogenic activity, systemic BCAA clearance, energy expenditure and overall metabolic health.

    • Haipeng Sun
    • Yibin Wang
    News & Views

    Advertisement

  • Dopamine is an important neurotransmitter with essential roles in movement control and salience, and implications in addiction as well as weight loss, decreased food intake and a reduced motivational drive to eat. Folgueira et al. now demonstrate that dopamine causes weight loss and increases brown adipose tissue temperature via activation of the dopamine receptor D2R in hypothalamic GABA-expressing neurons in mice, and treatment with the dopamine agonist cabergoline causes weight loss in humans.

    • Stephanie E. Simonds
    • Michael A. Cowley
    News & Views
  • Cells contributing to atherosclerotic disease are highly plastic and can shift their phenotype in a changing microenvironment. A study in Nature Metabolism now reveals that transforming growth factor-β (TGF-β) can transform endothelial cells into pro-inflammatory cells and that inhibition of TGF-β-receptor signalling in the endothelium can reverse atherosclerosis in mice.

    • Kathryn L. Howe
    • Jason E. Fish
    News & Views
Top of page ⤴

Comment & Opinion

Top of page ⤴

Research

Top of page ⤴

Amendments & Corrections

Top of page ⤴

Search

Quick links